Idexx Laboratories (IDXX) Stock Statistics & Valuation Metrics

Idexx Laboratories has a market cap or net worth of $51.16B. The enterprise value is $44.51B.

Idexx Laboratories has 80,004,690 shares outstanding. The number of shares has decreased by -2.65% in one year.

Idexx Laboratories’s return on equity (ROE) is 0.56 and return on invested capital (ROIC) is 33.87%.

The current PE Ratio of Idexx Laboratories is 52.8. Idexx Laboratories’s PEG ratio is ―.

In the last 12 months, Idexx Laboratories had revenue of 3.90B and earned 887.87M in profits. Earnings per share was 10.77.

In the last 12 months, operating cash flow was 905.81M and capital expenditures -131.47M, giving a free cash flow of 774.34M billion.

Idexx Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Idexx Laboratories upcoming earnings date is Nov 4, 2025, Before Open (Confirmed).

Idexx Laboratories as a current ratio of 1.31, with Debt / Equity ratio of 84.81%

In the past 12 months, Idexx Laboratories has paid 221.96M in taxes.

Idexx Laboratories EV to EBITDA ratio is 27.27, with an EV/FCF ratio of 43.60.

Idexx Laboratories has $164.59M in cash and marketable securities with $1.24B in debt, giving a net cash position of $1.07B billion.

Gross margin is 61.54%, with operating margin of 28.95%, and net profit margin of 22.78%.

The average price target for Idexx Laboratories is $724.38, which is 11.43% higher than the current price. The consensus rating is Moderate Buy